Clinical Trial Update: Efficacy Study of Topical Twice Weekly Fluticasone Treatment to Reduce Relapse in Atopic Dermatitis in Children [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating twice-weekly topical fluticasone to reduce relapse in children with atopic dermatitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Fluticasone propionate (topical) (fluticasone propionate)

Snippet

Sponsor: Elena Rubio Gomis | Conditions: Dermatitis, Atopic | Phase 3 | Status: TERMINATED